Net Sales

+18% (from 849,654K to 1,000,165K USD)

Net Sales increased approximately 18% YoY in Q1 2025 primarily driven by higher sales activity across all segments. The increase is attributed to contributions from recent acquisitions (e.g., Nehring and Elkhart), higher net selling prices—partly related to rising raw material costs—and growth in non-core product lines, building on factors from previous periods. " "

Operating Income

+12% (from 183,425K to 206,262K USD)

Operating Income grew roughly 12% YoY, reflecting improved operational efficiencies and gains on higher net selling prices. The current period benefited from the integration of acquired businesses and incremental sales growth, which built upon previous period improvements despite modest cost increases in areas such as selling, general, and administrative expenses. " "

Consolidated Net Income

+12% (from 141,709K to 159,287K USD)

Consolidated Net Income increased approximately 12% YoY due to the positive impact of stronger operating performance and gains on asset sales. The improvement reflects the continuation of higher sales volumes and operating income from prior periods, which offset certain higher expenses, thereby enhancing bottom‐line profitability. " "

Net Cash Provided by Operating Activities

-35% (from 173,625K to 113,559K USD)

Net Cash Provided by Operating Activities declined by about 35% YoY. Although net income improved, the operating cash flow suffered due to significant increases in working capital items such as accounts receivable and inventories. Additionally, cash used in financing activities—including large amounts attributable to stock repurchases and dividend payments—further pressured the cash conversion compared to the previous period. " "

Total Assets

+11.6% (from 2,894,242K to 3,231,304K USD)

Total Assets grew by approximately 11.6% YoY. This growth is driven by the continued impact of acquisitions that increased intangible assets (e.g., goodwill), along with higher balances in accounts receivable and inventories due to increased sales volumes, as well as strategic reallocation from cash to short-term investments as observed in the current period relative to prior periods. " "

Total Liabilities

+22% (from 445,872K to 544,205K USD)

Total Liabilities rose roughly 22% YoY mainly due to significant increases in current liabilities such as accounts payable and other current liabilities. These increases reflect the company’s expanded operational scale and the heightened volume of production and purchasing, which necessitated more credit from suppliers, as observed in the current period when compared to the previous one. " "

Cash and Cash Equivalents

-39% (from 1,357,952K to 830,100K USD)

Cash and Cash Equivalents declined significantly (about 39% YoY) as a result of heavy cash outflows in financing activities. The current period saw substantial use of cash for stock repurchases, dividend payments, and other financing expenses, coupled with the reallocation of cash into short-term investments, which contrasts with the higher cash balances observed in Q1 2024. " "